| 2010-December-31 |
LCT Executes AUD 5,750,000 Funding Agreement (in PDF) |
| 2010-December-23 |
LCT Negotiating Funding (in PDF) |
| 2010-December-20 |
LCT Approved to Further Expand DIABECELL® NZ Trial (in PDF) |
| 2010-December-10 |
LCT's DIABECELL® Registered for Sale and Use in Russia (in PDF) |
| 2010-November-18 |
LCT Appoints New Chairman (in PDF) |
| 2010-November-10 |
Promising Preclinical Results with NTCELL in Parkinson's (in PDF) |
| 2010-October-29 |
Appendix 4C Quarterly Cash Flow Report to 30 September 2010 (in PDF) |
| 2010-October-27 |
LCT Reports Sustained Improvement from DIABECELL NZ Trial (in PDF) |
| 2010-October-1 |
LCT Managing Director to Speak at American Investor Forum (in PDF) |
| 2010-September-23 |
LCT Restructures Executive Team for Commercial Focus (in PDF) |
| 2010-August-27 |
Preliminary Final Report for the Year Ended 30 June 2010 (in PDF) |
| 2010-August-6 |
Managing Director's Remuneration (in PDF) |
| 2010-August-4 |
LCT Receives Approval to Expand DIABECELL® NZ Trial (in PDF) |
| 2010-August-2 |
LCT Enhances Management Team: Managing Director Appointed (in PDF) |
| 2010-July-30 |
Appendix 4C Quarterly Cash Flow Report to 30 June 2010 (in PDF) |
| 2010-July-13 |
LCT Reports Consistent Benefit in DIABECELL® NZ Trial (in PDF) |
| 2010-June-28 |
LCT Presentation at American Diabetes Association (in PDF) |
| 2010-June-22 |
LCT Options Expiring 30th June 2010 to be Underwritten (in PDF) |
| 2010-June-10 |
LCT Works with NZ Government on Animal Derived Biologics (in PDF) |
| 2010-April-29 |
Appendix 4C Quarterly Cash Flow Report to 31 March 2010 (in PDF) |
| 2010-April-27 |
LCT Receives Grant from JDRF, Living Cell Technologies Receives Grant from Juvenile Diabetes Research Foundation International for DIABECELL® NZ Clinical Trial (in PDF) |
| 2010-April-13 |
Living Cell Technologies' Paper Selected for "Best Publications of 2009" by Journal of Neural Engineering (in PDF) |
| 2010-April-7 |
Report from LCT's Russian Phase I/IIa Diabetes Trial, Living Cell Technologies Confirms Safety and Proof of Principle of Efficacy in its Penultimate Data Analysis from its Russian Human Phase I/IIa Trial with DIABECELL® in Diabetics (in PDF) |
| 2010-March-30 |
LCT Phase II Diabetes Trial Success: Approval to Progress (in PDF) |
| 2010-March-10 |
Living Cell Technologies' Encapsulation Device Granted Registration in Russia (in PDF) |
| 2010-February-25 |
Living Cell Technologies Half Yearly Report Period Ended 31 December 2009 (in PDF) |
| 2010-February-12 |
Living Cell Technologies Awarded NZ$4.04 Million New Zealand Government Grant to advance DIABECELL® for type 1 diabetes (in PDF) |
| 2010-February-9 |
Living Cell Technologies Receives 10% of US Based Wound Healing Company in Supply and Licence Agreement (in PDF) |
| 2010-January-29 |
Appendix 4C Quarterly Cash Flow Report to 31 December 2009 (in PDF) |
| 2010-January-27 |
Living Cell Technologies Alerted to Issue of Fake Share Certificates (in PDF) |
| 2010-January-20 |
Living Cell Technologies Granted European Patent for Neurological Disease Product NTCELL (in PDF) |
| 2013 |
2013 Press Releases |
| 2012 |
2012 Press Releases |
| 2011 |
2011 Press Releases |
| 2009 |
2009 Press Releases |
| 2008 |
2008 Press Releases |
| 2007 |
2007 Press Releases |